Kamada reports mixed Q4 results; reaffirms FY25 outlook NewsToday, 7:10 AM Nice revenue build- Company Profile Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its commercial products include KAMRAB/KEDRAB for treating prophylaxis of rabies; CYTOGAM for Prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; GLASSIA for intravenous AATD; KAMRHO (D) IM for prophylaxis of hemolytic disease of newborns; KAMRHO (D) IV for immune thermobocytopunic purpura; and Echis coloratus and Vipera palaestinae Antiserum for the treatment of snake bite. The company also distributes imported drug products in Israel, including BRAMITOB to manage chronic pulmonary infection; FOSTER to treat asthma; TRIMBOW for chronic obstructive pulmonary disease; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; AEROBIKA, an OPEP device; RUPAFIN and RUPAFIN ORAL SOLUTION for allergic rhinitis and Urticaria; SINTREDIUS for rheumatoid arthritis, systemic lupus erythematosus, and mild-moderate juvenile dermatomyositis; IVIG for immunodeficiency-related conditions; VARITECT for chicken pox and zoster herpes; ZUTECTRA and HEPATECT CP for hepatitis B; MEGALOTECT CP for CMV virus; RUCONEST for angioedema attack; HEPARIN SODIUM INJECTION for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events; ALBUMIN and ALBUMIN for blood plasma; Factor VIII for hemophilia type A; and Factor IX for hemophilia type B. In addition, it distributes COAGADEX for hereditary factor X deficiency; IXIARO for Japanese encephalitis; VIVOTIF for Salmonella Typhi; PROCYSBI for nephropathic cystinosis; LAMZEDE for alpha-mannosidosis; ELIGARD for prostate cancer; and BEVACIZUMAB KAMADA for various cancers. The company was incorporated in 1990 and is headquartered in Rehovot, Israel. Large portfolio!
Guys we have a problem I just bought the second to last dozen eggs in the green market! and there was a bit of a scene. This Asian gal she had two dozen underneath her but looked to be reaching for other stuff so I touched one of her dozen and she snapped at me "They're mine".. I apologized and went to the last two dozen at the end of the table and I asked.. "are these yours too?" I know.. snarky) The Eggs cost $10 ! up $2 from last time I went I told you all we have a big fucking problem here in the pipeline. I told you! $20 eggs? Only the rich can eat eggs.. is that the future (and the plan).... what if I owned a bakery!!!! Fucking A. Listen under Biden eggs were $6 and $7 and people were upset then what now Maggots? With $10 Eggs under Frump! What say you now....This is escalating inflation!!!!!
our Lumen.. and WAY are acting well///---- WAY Waystar Holding Corp. $43.50 1.58 (+3.77%)1:11 PM 03/05/25 NASDAQ | $USD | Realtime
TOST Toast, Inc. $35.88 0.70 (+1.99%)1:23 PM 03/05/25 NYSE | $USD | Realtime Mixed feelings here. We'll get into it later it is holding up well & has attractive growth prospects. Chart is iffy could go either way but downside risk is $20 which is too much for me. That being said if the market turns up this will run fast a lot of heavy hitters involved./
I'm on hold now with the company. Office A, Tower A, Capital Tower 15/F No. 38 Wai Yip Street Kowloon Bay Hong Kong